Academic Article
RDF
pages:
-
A peptide‐based bifunctional chelating agent for 99mtc‐ and 186re‐labeling of monoclonal antibodies
-
A Performing Arts Intervention Improves Cognitive Dysfunction in 50 Hospitalized Older Adults
-
A peripheral mechanism preserves self-tolerance to a secreted protein in transgenic mice
-
A periplasmic cinched protein is required for siderophore secretion and virulence of Mycobacterium tuberculosis
-
A persistent(ly) enigmatic ecological mystery: Bacterial vaginosis
-
A Perspective on the Transition to Plant-Based Diets: A Diet Change May Attenuate Climate Change, but Can It Also Attenuate Obesity and Chronic Disease Risk
-
A phantom study of the effect of heart rate, coronary artery displacement and vessel trajectory on coronary artery calcium score: Potential for risk misclassification
-
A phantom-based calibration method for digital X-ray tomosynthesis
-
A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer
-
A pharmacogenetic versus a clinical algorithm for warfarin dosing
-
A pharmacokinetic and clinical evaluation of switching patients with bipolar I disorder from delayed-release to extended-release divalproex
-
A pharmacological model for calcium overload-induced tachycardia in isolated rat left atria
-
A pharmacovigilance study of hydroxychloroquine cardiac safety profile: Potential implication in COVID‐19 mitigation
-
A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma
-
A phase 1 trial of oncolytic HSV-1, g207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses
-
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia
-
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML
-
A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons with HIV-1 on Suppressive Antiretroviral Therapy
-
A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy.
-
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer
-
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
-
A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis
-
A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)
-
A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia
-
A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases
-
A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia
-
A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea
-
A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia
-
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas
-
A phase 2, controlled, dose-ranging study of SB208, an investigational topical nitric oxide-releasing drug, for the treatment of tinea pedis
pages:
